4.7(top 8%)
Impact Factor
5.1(top 8%)
extended IF
133(top 2%)
H-Index
2.9K
authors
5.9K
papers
166.4K
citations
4.4K
citing journals
35.3K
citing authors

Most Cited Articles of Biology of Blood and Marrow Transplantation

TitleYearCitations
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report20052.7K
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective20091.2K
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report20151.2K
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide20081.2K
Defining the intensity of conditioning regimens: working definitions20091.1K
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells2019874
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients2005675
Chronic graft-versus-host disease2003654
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease2015415
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome2010406
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation2012399
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans2010383
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation2005375
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report2006357
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies2003348
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report2006344
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease2009339
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease2014336
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide2002335
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation2005331
Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers2001328
Transplantation of ex vivo expanded cord blood2002326
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems2002310
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation2006287
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report2006287